In A Nutshell High-throughput drug screening identified rigosertib as highly selective for ovarian cancer cells. Alone, rigosertib shuts down one survival pathway but triggers compensatory activation ...

Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

Hepatitis B is relatively frequent in the Bouaké military region, with a prevalence of 5.23%. It predominantly affects ...